Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Roche and Genentech describe novel PI3K inhibitors for cancer therapy

Feb. 9, 2010

Israeli scientists disclose novel calcipotriol analogues

Feb. 9, 2010

Phase I data show acceptable safety of BIBF-1120 in gynecological tumors

Feb. 9, 2010

Phase II results encourage further study of perifosine for Waldenstrom's macroglobulinemia

Feb. 9, 2010

Novel compounds for cancer therapy discovered by Japanese scientists

Feb. 8, 2010

ArQule initiates phase II trial of ARQ-197 in GCT and phase I/II trial in CRC

Feb. 8, 2010

Johns Hopkins University and FASgen claim novel oncolytic agents

Feb. 8, 2010

Natural products with oncolytic activity identified by South African scientists

Feb. 8, 2010

BioMarin signs stock purchase agreement to acquire LEAD Therapeutics and LT-673

Feb. 8, 2010

Novartis describes efforts to target PDK1 in oncology

Feb. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...